openPR Logo
Press release

CRISPR/Cas 9 Gene Editing In Drug Discovery Trends 2016

11-29-2016 01:00 PM CET | Health & Medicine

Press release from: ReportsWorldwide

ReportsWorldwide has announced the addition of a new report CRISPR/Cas 9 Gene Editing In Drug Discovery Trends 2016 to its growing collection of premium market research reports.

This market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on CRISPR/Cas 9 gene editing in drug discovery carried out in February 2016.

The survey was initiated by HTStec as part of its tracking of emerging life science marketplaces.

The questionnaire was compiled to meet the needs, requirements and interests of the gene editing reagents vendor community. The objective was to comprehensively document the current use of CRISPR (clustered regularly interspaced short palindromic repeats) and the associated nuclease Cas 9 in gene editing in drug discovery applications and to understand its future impact.
Equal emphasis was given to soliciting opinion from all areas and organisations where CRISPR/Cas 9 gene editing is being utilised as part of drug discovery efforts.

To view a detailed description and Table of Contents please visit: https://www.reportsworldwide.com/report/crisprcas-9-gene-editing-in-drug-discovery-trends-2016

The survey looked at the following aspects of CRISPR/Cas 9 gene editing technology as practiced today (2016) and in some cases as predicted for the future (2018):

• current experience of gene editing;
• when first started using gene editing;
• extent utilizing in drug discovery;
• number of FTE working in respondent's organisation on gene editing;
• key diseases or research areas using gene editing;
• what respondents want to achieve with gene editing;
• genomes being targeted with gene editing;
• main objectives of gene editing efforts in drug discovery;
• advantages of CRISPR/Cas 9 gene editing technology;
• potential benefits of CRISPR/Cas 9 in drug discovery respondents most want to exploit;
• most relevant features of CRISPR/Cas 9 gene editing technology to respondent's research effort;
• bioinformatics tools used to design guide RNAs (sgRNAs);
• how CRISPR/Cas 9 components are delivered into cells;
• methods used for CRISPR experiments;
• use of different cell types in CRISPR research;
• percentage efficiency of gene editing typically achieved;
• downstream analysis techniques used to validate your CRISPR/Cas 9 gene editing;
• number of sgRNAs designed per gene targeted;
• use of multiplexed gene edits;
• use of CRISPR libraries for target validation or drug mechanism studies and which type of libraries preferred;
• cellular response endpoints of greatest value in the functional screening of CRISPR libraries;
• number of different CRISPR/Cas 9 gene editing projects attempted per year;
• budget for purchasing CRISPR/Cas 9 gene editing related reagents and breakdown into components;
• supplier/vendor that first comes to mind when thinking of CRISPR/Cas 9 gene editing related reagents;
• suppliers where respondents currently purchase the majority of their CRISPR/Cas 9 gene editing related reagents;
• what most limits work on CRISPR/Cas 9 gene editing today;
• and any unmet needs that exist in CRISPR/Cas 9 gene editing related to drug discovery today.

To enquire about this Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=17

About ReportsWorldwide.com

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-4994
Fax +1 (617) 398-4995
abigail@reportsworldwide.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CRISPR/Cas 9 Gene Editing In Drug Discovery Trends 2016 here

News-ID: 388639 • Views: 389

More Releases from ReportsWorldwide

World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports. Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors. Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports. This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers: • CommScope/Airvana • Comba Telecom • Ericsson • Huawei Technologies • Nokia • SpiderCloud • ZTE Corporation This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021. To view a detailed description and Table of
UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply …
Boston, MA ReportsWorldwide has announced the addition of a new report title UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply Chain in India – 2017 to its growing collection of premium market research reports. UDAY scheme was touted as the next paladin to bail out the struggling Discoms, in order to turn them green in a time horizon of 3-4 years from 2015/16. Though was optional for the

All 5 Releases


More Releases for CRISPR

CRISPR Expanding the Gene Editing Technology Market
CRISPR is a major breakthrough considered in the field of biotechnology. The technology is capable of performing the actions that are lacking in the traditional genome editing technologies. The technology is capable of precisely altering the target DNA and carry out the required action. The technology of CRISPR is shorthand for CRISPR-Cas9. The unique function of Cas9 to perform as a molecular scissor is driving the performance rate of CRISPR
CRISPR and CRISPR-Associated (Cas) Genes Market Key players 2017-2025 : Caribou …
Global CRISPR and CRISPR-Associated (Cas) Genes Market: Snapshot Over the years, biomedical researchers have increasingly focused on developing efficient and reliable methods for precise and targeted changes to virtually any point of genome of any living cell. Recent advances in the genome engineering has triggered several biological researches and translational applications. Economical manipulation and modification of genomic sequences enable molecular biologists identify and characterize key genetic determinants to facilitate the investigation
CRISPR and CRISPR-Associated (Cas) Genes Market Evaluation and Dimensions On 202 …
Global CRISPR and CRISPR-Associated (Cas) Genes Market: Snapshot Over the years, biomedical researchers have increasingly focused on developing efficient and reliable methods for precise and targeted changes to virtually any point of genome of any living cell. Recent advances in the genome engineering has triggered several biological researches and translational applications. Economical manipulation and modification of genomic sequences enable molecular biologists identify and characterize key genetic determinants to facilitate the investigation
CRISPR and CRISPR-Associated (Cas) Genes Market : Strategy Resources, Manufactur …
Global CRISPR and CRISPR-Associated (Cas) Genes Market: Snapshot Over the years, biomedical researchers have increasingly focused on developing efficient and reliable methods for precise and targeted changes to virtually any point of genome of any living cell. Recent advances in the genome engineering has triggered several biological researches and translational applications. Economical manipulation and modification of genomic sequences enable molecular biologists identify and characterize key genetic determinants to facilitate the investigation
CRISPR and CRISPR-Associated (Cas) Genes Market - Overview of Industry & Forecas …
Global CRISPR and CRISPR-Associated (Cas) Genes Market: Snapshot Over the years, biomedical researchers have increasingly focused on developing efficient and reliable methods for precise and targeted changes to virtually any point of genome of any living cell. Recent advances in the genome engineering has triggered several biological researches and translational applications. Economical manipulation and modification of genomic sequences enable molecular biologists identify and characterize key genetic determinants to facilitate the investigation
Global CRISPR And CRISPR-Associated (Cas) Genes Market Share, Revenue and Foreca …
Market Research Hub (MRH) has announced the inclusion of a new market research study to its comprehensive collection of research reports. The 165-page research study, titled “Global CRISPR And CRISPR-Associated (Cas) Genes Market” offers a detailed analysis of the market, focusing on the growth prospects in the next few years. Furthermore, the research report throws light on drivers and challenges in the objective lens market in the